Periostin in skin tissue and skin-related diseases

Allergology International

Volumn 63, Issue 2, 2014, Pages 161-170

  Yamaguchi, Yukie ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Fibrosis; Matricellular protein; Periostin; Remodeling

Indexed keywords

COLLAGEN; TRANSCRIPTION FACTOR RUNX2; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ATOPIC DERMATITIS; CUTANEOUS PARAMETERS; HUMAN; NONHUMAN; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN ALLERGY; SKIN DEVELOPMENT; SKIN DISEASE; SKIN FIBROSIS; SKIN INJURY; SYSTEMIC SCLEROSIS; WOUND HEALING; AGING; ANIMAL; EMBRYOLOGY; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; SKIN; SKIN DISEASES;

AGING; ANIMALS; CELL ADHESION MOLECULES; COLLAGEN; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; PHENOTYPE; SKIN; SKIN DISEASES; WOUND HEALING;

EID: 84901978331     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.13-RAI-0685     Document Type: Review

References (86)

1. Madison KC. Barrier function of the skin: "la raison d'être" of the epidermis. J Invest Dermatol 2003;121:231-41.
2. Boulais N, Misery L. The epidermis: a sensory tissue. Eur J Dermatol 2008;18:119-27.
3. Ozbek S, Balasubramanian PG, Chiquet-Ehrismann R, Tucker RP, Adams JC. The evolution of extracellular matrix. Mol Biol Cell 2010;21:4300-5.
4. Berrier AL, Yamada KM. Cell-matrix adhesion. J Cell Physiol 2007;213:565-73.
5. Uitto J, Olsen DR, Fazio MJ. Extracellular matrix of the skin: 50 years of progress. J Invest Dermatol 1989;92 (Suppl):61S-77.
6. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007;117:568-75.
7. Larsen M, Artym VV, Green JA, Yamada KM. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol 2006;18:463-71.
8. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009;326:1216-9.
9. Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2008;2:9-17.
10. Ruan K, Bao S, Ouyang G. The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 2009;66:2219-30.
11. Takayama G, Arima K, Kanaji T et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 2006;118:98-104.
12. Norris RA, Damon B, Mironov V et al. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 2007;101:695-711.
13. Kii I, Nishiyama T, Li M et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem2010;285: 2028-39.
14. Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann N Y Acad Sci 2008;1123:30-40.
15. Frangogiannis NG. Matricellular proteins in cardiac adaptation and disease. Physiol Rev 2012;92:635-88.
16. Horiuchi K, Amizuka N, Takeshita S et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 1999;14:1239-49.
17. Tai IT, Dai M, Chen LB. Periostin induction in tumor cell line explants and inhibition of in vitro cell growth by antiperiostin antibodies. Carcinogenesis 2005;26:908-15.
18. Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Res 2002;62: 5358-64.
19. Oka T, Xu J, Kaiser RA et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 2007;101:313-21.
20. Shimazaki M, Nakamura K, Kii I et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 2008;205:295-303.
21. Norris RA, Moreno-Rodriguez RA, Sugi Y et al. Periostin regulates atrioventricular valve maturation. Dev Biol 2008; 316:200-13.
22. Hakuno D, Kimura N, Yoshioka M et al. Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest 2010;120:2292-306.
23. Oku E, Kanaji T, Takata Y et al. Periostin and bone marrow fibrosis. Int J Hematol 2008;88:57-63.
24. Okamoto M, Hoshino T, Kitasato Y et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J 2011;37:1119-27.
25. Uchida M, Shiraishi H, Ohta S et al. Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 2012;46: 677-86.
26. Yamaguchi Y, Ono J, Masuoka M et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermato 2013;168: 717-25.
27. Hayashi N, Yoshimoto T, Izuhara K, Matsui K, Tanaka T, Nakanishi K. T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-bband IL-13 production. Proc Natl Acad Sci U S A 2007;104:14765-70.
28. Blanchard C, Mingler MK, McBride M et al. Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 2008;1:289-96.
29. Ishida A, Ohta N, Suzuki Y et al. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int 2012;61:589-95.
30. Masuoka M, Shiraishi H, Ohta S et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012;122:2590-600.
31. Shiraishi H, Masuoka M, Ohta S et al. Periostin contributes to the pathogenesis of atopic dermatitis by inducing TSLP production from keratinocytes. Allergol Int 2012; 61:563-72.
32. Jackson-Boeters L, Wen W, Hamilton DW. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal 2009;3:125-33.
33. Zhou HM, Wang J, Elliott C, Wen W, Hamilton DW, Conway SJ. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J Cell Commun Signal 2010;4:99-107.
34. Nishiyama T, Kii I, Kashima TG et al. Delayed reepithelialization in periostin-deficient mice during cutaneous wound healing. PLoS One 2011;6:e18410.
35. Elliott CG, Wang J, Guo X et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci 2012;125:121-32.
36. Ontsuka K, Kotobuki Y, Shiraishi H et al. Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts. Exp Dermatol 2012;21:331-6.
37. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergol Int 2014;63:143-51.
38. Matsumoto H. Serum periostin: a novel biomarker for asthma management. Allergol Int 2014;63:153-60.
39. Ohta N, Ishida A, Kurakami K et al. Expressions and roles of periostin in otolaryngological diseases. Allergol Int 2014;63:171-80.
40. Tilman G, Mattiussi M, Brasseur F, van Baren N, Decottignies A. Human periostin gene expression in normal tissues, tumors and melanoma: evidences for periostin production by both stromal and melanoma cells. Mol Cancer 2007;6:80.
41. Egbert M, Ruetze M, Sattler M et al. The matricellular protein periostin contributes to proper collagen function and is downregulated during skin aging. J Dermatol Sci 2014;73:40-8.
42. Rios H, Koushik SV, Wang H et al. Periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol 2005; 25:11131-44.
43. Kii I, Amizuka N, Minqi L, Kitajima S, Saga Y, Kudo A. Periostin is an extracellular matrix protein required for eruption of incisors in mice. Biochem Biophys Res Commun 2006;342:766-72.
44. Kadler KE, Hill A, Canty-Laird EG. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol 2008;20:495-501.
45. Martinek N, Shahab J, Sodek J, Ringuette M. Is SPARC an evolutionarily conserved collagen chaperone? J Dent Res 2007;86:296-305.
46. Banse X, Sims TJ, Bailey AJ. Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res 2002;17: 1621-8.
47. Maruhashi T, Kii I, Saito M, Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem2010;285:13294-303.
48. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
49. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453:314-21.
50. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP. Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 2005;25:77-83.
51. Goetsch SC, Hawke TJ, Gallardo TD, Richardson JA, Garry DJ. Transcriptional profiling and regulation of the extracellular matrix during muscle regeneration. Physiol Genomics 2003;14:261-71.
52. Elliott CG, Kim SS, Hamilton DW. Functional significance of periostin in excisional skin repair: is the devil in the detail? Cell Adh Migr 2012;6:319-26.
53. Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 2007; 302:256-66.
54. Baril P, Gangeswaran R, Mahon PC et al. Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathway. Oncogene 2007;26:2082-94.
55. Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics 2008;9:548-55.
56. Li G, Jin R, Norris RA et al. Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 2010;208:358-65.
57. Watanabe T, Yasue A, Fujihara S, Tanaka E. PERIOSTIN regulates MMP-2 expression via the avr3 integrin/ERK pathway in human periodontal ligament cells. Arch Oral Biol 2012;57:52-9.
58. Rosselli-Murai LK, Almeida LO, Zagni C et al. Periostin responds to mechanical stress and tension by activating the MTOR signaling pathway. PLoS One 2013;8:e83580.
59. Taniguchi K, Arima K, Masuoka M et al. Periostin Controls Keratinocyte Proliferation and Differentiation by Interacting with the Paracrine IL-1w/IL-6 Loop. J Invest Dermatol 2013. DOI:10.1038/jid.2013.500.
60. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007;117:524-9.
61. Branton MH, Kopp JB. TGF-BBand fibrosis. Microbes Infect 1999;1:1349-65.
62. Leask A, Abraham DJ, Finlay DR et al. Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum 2002;46:1857-65.
63. Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol 2012;26:141-52.
64. Yang L, Serada S, Fujimoto M et al. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One 2012;7:e41994.
65. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557-67.
66. Yamamoto T, Takagawa S, Katayama I et al. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 1999;112:456-62.
67. Hu B, Phan SH. Myofibroblasts. Curr Opin Rheumatol 2013;25:71-7.
68. Shi-wen X, Stanton L, Kennedy L et al. CCN2 is necessary for adhesive responses to TGFf1 in embryonic fibroblasts. J Biol Chem2006;281:10715-26.
69. Leask A, Abraham DJ. All in the CCN family. J Cell Sci 2006;119:4803-10.
70. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22:1281-5.
71. Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005;116:477-86.
72. Sidhu SS, Yuan S, Innes AL et al. Roles of epithelial cellderived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A 2010;107:14170-5.
73. Bousquet J, Jacot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004;113:43-9.
74. Cheng E, Souza RF, Spechler SJ. Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2012;303:G1175-87.
75. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-18.
76. Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 2009;129:742-51.
77. Yuyama N, Davies DE, Akaiwa M et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002; 19:287-96.
78. Corren J, Lemanske RF, Hanania NA et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365: 1088-98.
79. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361: 151-60.
80. Tazawa T, Sugiura H, Sugiura Y, Uehara M. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res 2004;295:459-64.
81. Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci 2013;70:3-11.
82. Palmer CN, Irvine AD, Terron-Kwiatkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
83. Tanaka A, Amagai Y, Oida K, Matsuda H. Recent findings in mouse models for human atopic dermatitis. Exp Anim 2012;61:77-84.
84. Ito T, Liu YJ, Arima K. Cellular and molecular mechanisms of TSLP function in human allergic disorders-TSLP programs the "Th2 code" in dendritic cells. Allergol Int 2012;61:35-43.
85. Kou K, Okawa T, Yamaguchi Y et al. Periostin levels correlate disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol. DOI: 10.1111/bjd.12943.
86. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-41.